Basel Kayyali

Regulation doesn’t have to slow you down — with the right system, it accelerates you. After more than three years of development and optimization, our Easy13485 QM Service is now fully mature. — built on over 25 years of experience leading successful medical innovation projects. A unique part of our commitment: we take responsibility for all Framework Non-Conformities identified by the Notified Body — at our own cost 💵 . This keeps the regulatory risk for start-ups predictably low and allows them to focus on product and funding milestones. 2025 we added a comprehensive Academy to the Easy13485 QM Service Framework — more than 150 role-based trainings that allow every team member to become audit-ready independently. This closes one of the biggest gaps in regulatory reliability for early-stage companies and simplifies #onboarding for #fast-growing teams. 𝗢𝘂𝗿 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗺𝗼𝗱𝗲𝗹 𝗶𝘀 𝗱𝗲𝗹𝗶𝗯𝗲𝗿𝗮𝘁𝗲𝗹𝘆 𝘂𝗻𝗰𝗼𝗻𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝗮𝗹 While most #eQMS systems focus on automating recurring documentation tasks, #Easy13485 eliminates them by design. 🦉 Instead of making regulatory work faster, we make most of it unnecessary — replacing traditional consultants and, in a way, 𝗰𝗮𝗻𝗻𝗶𝗯𝗮𝗹𝗶𝘇𝗶𝗻𝗴 𝗼𝘂𝗿𝘀𝗲𝗹𝘃𝗲𝘀. We’re excited for this year’s #4CUnplugged, of Medical Innovations Incubator GmbH not only to meet our existing customers but also to engage with new start-ups as a premium partner. Ready to take on new projects in 2026.

9

Capital doesn’t create impact — discipline does. As life sciences enters a new era of capital intensity, the challenge isn’t just how much we invest, but how effectively we deploy it. From manufacturing expansion to new modalities and digital infrastructure, capital excellence will define which companies can turn investment into faster, more reliable patient outcomes. In healthcare innovation, efficiency isn’t just operational — it’s moral. Every dollar deployed well brings lifesaving therapies closer to the people who need them most. #LifeSciences #HealthInnovation #Investment #HealthcareLeadership

2

When we started our Health vertical, we wanted to make the industry better by bringing the right people together for innovation to thrive. Since 2015, I’ve seen how powerful this mission has become as we’ve connected innovators, healthcare leaders, and local institutions around the world. Our partnerships with organizations like Pfizer, Roche, Bayer, GuideWell, NEOM, Tavistock Development Company, Ivoclar, and the University of Birmingham help create positive impact for our startups by supporting them as they pilot, scale, and deliver improved solutions to patients and healthcare professionals. Thank you to our teams and partners shaping the future of health with us. Watch the full video here: https://pnptc.in/4oUQ7Cg #PNPTC #PNPTCHealth Plug and Play Tech Center, Plug and Play Health, Osama Alsaleh, Ayah Hamdan

110

4 Comments

Nice quote from one of our Partners Andrew Brackin in TechCrunch: “This was one of the biggest use cases of ChatGPT,” Andrew Brackin, a partner at Gradient who invests in health tech, told TechCrunch. “So it makes a lot of sense that they would want to build a more kind of private, secure, optimized version of ChatGPT for these healthcare questions.” https://lnkd.in/gY3TV5VD

27

1 Comment

FORCING CHANGE IN SITE OF CARE McKinsey & Company's recent paper on the forces pressuring healthcare, including the possibility of margin compression of up to 13 percentage points for health systems, does a good job of putting numbers around what most operators already feel. Two of the biggest drivers they mention are policy shifts in reimbursement and rising utilization driven by an aging population. The cohort of 70+ year old Americans will grow the fastest over the next 5 years, and it is well established that older patients have more complex needs, more chronic disease, and more touchpoints within the healthcare system. Layer that on top of continued clinical workforce shortages, and the supply-demand gap widens further. From my perspective, optimizing for site of care is the most important lever we have to address this challenge. We can’t quickly reduce how much care older patients need, but we can change where and how services are delivered. Supporting aging patients in lower-cost settings like the home, ambulatory sites, and virtual environments is no longer just a preference or convenience, it’s a necessity. This is where the conversation around site-neutral payments becomes so relevant. CMS is moving quickly in this direction, and hospital outpatient departments (HOPDs) are squarely in the crosshairs. The shift will undoubtedly clamp down further on hospital margins, but it shouldn’t be surprising. We’ve been talking about the demise of HOPD reimbursement for years, and the health systems that will fare best are the ones who are working towards aligning their approach with where patients can be treated safely, efficiently, and at lower cost, rather than relying on legacy reimbursement structures to fill the gap. And just like it doesn’t make sense to try to replicate a hospital or nursing home environment in a patient’s home, we also shouldn’t try to carry the same clinical staffing model into every care setting. Yes, there are non-negotiables when it comes to patient safety and clinical expertise, but there’s also a meaningful opportunity to rethink how teams are built. That means clinicians at every level working at the top of their licenses, thoughtfully involving family members and community resources, and using technology to surround these sites of care with non-clinical operational support. From my health system days, I understand why rising costs, margin pressure, and site-neutral payments feel like threats. While painful, I’m hopeful they can also serve as a positive forcing function, pushing us toward care models that are better aligned with our aging population and the realities of today’s workforce.

23

1 Comment